Please assess the completion status of the following clinical trial:

Trial Title: Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Criteria of SIRS: at least 2 of 4:~  * Temperature \> 38 °c or \< 36 ° C~ * More than 90 bpm heart rate~ * Respiratory rate more than 20rpm or PaCO2 less than 32 mm Hg or patient in mechanical ventilation~ * Less than 4000/ mm³ or more than 12000/mm³, or more than 10% leukocyte bands (immature)~* Septic source known demonstrated (or at least of high probability) and controlled (if it is controllable)~* Hematocrit 25% or higher and/or hemoglobin 8 g/dL or higher. If necessary, transfuse RBCs to meet this criteria~* MAP less than 70 mm Hg. Note there is no requirement for adequate preload evidence~Exclusion Criteria:~* Hypernatremia at base-line of 155 mEq/L or greater Hyponatremia at base-line less than 130mEq / L~* Prior endocrine disease affecting to the adrenal-pituitary axis.~* Intracranial Hypertension, brain tumor, seizures, head trauma~* Coronary Artery Disease active over the past year; or evidence of myocardium at risk by exercise stress test, pharmacological or positive gammagraphy last year without intervention~* Pregnancy~* Liver disease Child C, End-Stage-Renal-Disease~* Under the age of 18~* Patients with order do not resuscitate or with minimal chances to survive

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Hypertonic Saline and Terlipressin (Type: EXPERIMENTAL): None
- Normal Saline and norepinephrine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).